Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,793,000 | 4,046,000 | 4,004,000 | 3,833,000 | 4,743,000 |
| Marketable Securities | 80,000 | 81,000 | 76,000 | 78,000 | 82,000 |
| Inventories | 5,788,000 | 5,943,000 | 5,659,000 | 5,557,000 | 5,661,000 |
| Other current assets | 7,757,000 | 6,974,000 | 6,684,000 | 6,131,000 | 7,170,000 |
| TOTAL | $17,418,000 | $17,044,000 | $16,423,000 | $15,907,000 | $17,656,000 |
| Non-Current Assets | |||||
| PPE Net | 10,923,000 | 10,823,000 | 10,661,000 | 10,860,000 | 10,633,000 |
| Intangibles | 23,111,000 | 23,072,000 | N/A | 23,296,000 | 23,685,000 |
| Other Non-Current Assets | 7,152,000 | 6,696,000 | 29,075,000 | 6,318,000 | 6,809,000 |
| TOTAL | $41,186,000 | $40,591,000 | $39,736,000 | $40,474,000 | $41,127,000 |
| Total Assets | $58,604,000 | $57,635,000 | $56,159,000 | $56,381,000 | $58,783,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,802,000 | N/A |
| Accounts payable and accrued liabilities | 13,093,000 | 12,545,000 | 21,088,000 | 3,528,000 | 19,840,000 |
| Other current liabilities | 818,000 | 806,000 | 732,000 | 1,076,000 | 917,000 |
| TOTAL | $18,395,000 | $18,198,000 | $26,927,000 | $26,569,000 | $27,438,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 14,221,000 | N/A |
| Other Non-Current Liabilities | 36,016,000 | 35,856,000 | 20,591,000 | 7,106,000 | 21,065,000 |
| TOTAL | $36,486,000 | $36,414,000 | $25,642,000 | $26,323,000 | $26,516,000 |
| Total Liabilities | $54,881,000 | $54,612,000 | $52,569,000 | $52,892,000 | $53,954,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,344,000 | 1,343,000 | 1,343,000 | 1,343,000 | 1,343,000 |
| Retained earnings | -2,081,000 | -2,680,000 | -6,353,000 | -6,477,000 | -5,349,000 |
| Other shareholders' equity | 2,164,000 | 1,974,000 | 1,911,000 | 2,047,000 | 2,289,000 |
| TOTAL | $4,476,000 | $3,679,000 | $-69,000 | $-68,000 | $1,294,000 |
| Total Liabilities And Equity | $59,357,000 | $58,291,000 | $52,500,000 | $52,824,000 | $55,248,000 |